Mirum Pharmaceuticals, Inc. (MIRM) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Mirum Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -169.72x | -22.35x | -7.39x | -4.86x | -5.76x | -4.27x |
| P/B Ratio | 12.60x | 8.71x | 4.85x | 4.65x | 4.02x | 2.56x |
| P/S Ratio | 7.61x | 5.83x | 6.48x | 8.56x | 25.27x | 0.00x |
| Profitability | ||||||
| Gross Margin | 80.7% | 75.8% | 74.8% | 83.9% | 90.1% | 0.0% |
| Operating Margin | -4.2% | -26.0% | -58.6% | -170.3% | -906.1% | 0.0% |
| Net Margin | -4.5% | -26.1% | -87.7% | -176.0% | -438.9% | 0.0% |
| EBITDA Margin | 3.3% | -14.5% | -73.2% | -159.4% | -341.7% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 2.67x | 3.10x | 4.45x | 2.94x | 3.91x | 12.80x |
| Quick Ratio | 2.55x | 2.93x | 4.19x | 2.85x | 3.88x | 12.80x |
| Leverage | ||||||
| Debt/Equity | 1.02x | 1.41x | 1.24x | 0.02x | 0.02x | 0.02x |
YoY = year-over-year change. Source: FMP..